Paraguay approved two cannabis products as medicines, allowing cannabidiol (CBD oil) Real Scientific Hemp Oil-X™ (RSHO-X™) and RSHO™ Blue Label by Medical Marijuana Inc.
While Paraguay has long been known as a world leader in producing black market cannabis, it has been illegal to grow cannabis in Paraguay until just last week.
Paraguay’s congress passed a bill on Dec. 5 creating a state-sponsored system to import cannabis seeds and grow medical cannabis, a decision that followed Peru, Chile, Argentina and Colombia’s medical cannabis legalization. Uruguay has fully legalized growing and selling cannabis for any use, according to Reuters.
This marks only the third botanical cannabis product to be approved as a medicine in the world. Many European countries approved cannabinoid medicine Sativex, an oral spray for MS Spasticity and chronic cancer pain, in 2013.
Epidiloex, a cannabinoid medicine for epilepsy syndromes, has also been approved in Europe and is being considered for approval by the United States’ Food & Drug Administration. There is one other approved cannabis product called Marinol, which treats vomiting symptoms from cancer medications, but it is synthetic versus botanical.
Medical Marijuana, Inc. CBD oil products will be available through Paraguay’s medical distribution channels. The company is the first publicly traded cannabis company in the United States.
Real Scientific Hemp Oil-X™ is used to treat epilepsy symptoms and chronic pain. It is non-psychoactive with trace amounts of THC.
“This is yet another example of the international trend of acceptance of medical research on CBD for medical use,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
“We are continually encouraged by the decisions of governments to permit use of our products for patients suffering from multiple medical indications, where conventional medicine has had modest effects.”
Medical Marijuana, Inc.’s CBD hemp oil products have been used by over 100 citizens in Paraguay with medical indications ranging from cancer, pain, multiple sclerosis, epilepsy and various other neurological diseases, according to a release. In 2016, Real Scientific Hemp Oil™ became the first medical cannabis product approved and imported for use in Paraguay as a supplement.
“We are a company of firsts, and we are excited about this new historic milestone of being the only company to have a CBD product registered in Paraguay,” said Titus.
Earlier this year, RSHO™ was also the first cannabis product approved for Brazil and Mexico. Medical Marijuana, Inc. reported a total gross profit of 297 percent compared to Q3 2016, after focusing on international expansion and cannabinoid research this year.
Sign up for the green rush. Subscribe to our newsletter.
The State of Mexico is making a historic buy of Medical Marijuana, Inc.’s HempMeds Mexico merchandise for its residents, beginning with 11 epilepsy and most cancers sufferers. Actual Scientific Hemp Oil-X™ (RSHO-X™) is cannabinoid hemp oil with zero THC.
That is the primary time a authorities in Mexico has bought CBD merchandise for its residents. The Mexican authorities’s transfer can be just like Medicaid masking medical hashish right here within the states, and is a large improvement in medical hashish historical past. A report revealed in Well being Affairs discovered that if all American states had legalized medical marijuana in 2014, Medicaid might have saved $1 billion in spending on prescriptions.
To mark the announcement, State of Mexico Governor Eruviel Avila distributed HempMeds Mexico’s flagship product Actual Scientific Hemp Oil-X™ to the primary 11 epilepsy and most cancers sufferers on the inauguration of a brand new hospital within the State of Mexico on Thursday, August 17, 2017.
Quite a few sufferers with neurological illnesses, lung illness, epilepsy and different well being issues have reported that they use fewer prescription medicines and have seen exceptional progress after utilizing HempMeds merchandise.
Almost half of cannabidiol sufferers cease utilizing conventional medicines in response to a currentreport on CBD oil consumer expertise by Brightfield Group and HelloMD, who anticipate that the entire cannabidiol market will attain $467 million in 2017.
Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico, lately shared the constructive outcomes of a current research he carried out on the consequences of Medical Marijuana, RSHO-X™ product in treating youngsters with extreme epilepsy, through which 86 % of the 29 sufferers he studied skilled statistically vital (higher than 50%) discount in motor seizures. Seventeen % of the youngsters have been absolutely seizure free for a Four-month interval.
HempMeds® Mexico is the primary firm to obtain authorities import permits for a hashish product by way of approval by the Mexican Well being Division, COFEPRIS.
HempMeds made worldwide information final month for opening its Monterrey, Mexico workplace, which serves because the hub for distribution of RSHO-X™ to Mexican distributors and sufferers.
Mexico legalized the cultivation, manufacturing, and use of hashish merchandise with lower than one % THC for medical use when President Pena Nieto signed a invoice into regulation on June 19.
“We need to congratulate the State of Mexico’s authorities for this historic buy of our CBD merchandise to assist relieve the struggling of its residents,” stated Medical Marijuana, Inc. Dr. Stuart Titus. “We’re a Firm of firsts and we’re enthusiastic about this new historic milestone of being the primary Firm that a authorities has bought our CBD merchandise to profit its residents. The plethora of advantages of medical hashish to deal with a number of kinds of indications in plain and we’re inspired to see not solely well being skilled, but in addition now governments, have gotten more and more concerned with how CBD hemp oil may help heal.”
HempMeds® Mexico is the primary firm to obtain authorities import permits for a hashish product by way of approval by the Mexican Well being Division, COFEPRIS.
Mexico represents a possible $1 to $2 billion cannabidiol (CBD) hemp oil market over the subsequent ten years for Medical Marijuana, Inc, a part of an anticipated upward international development for the business to succeed in $63.5 billion by 2024. The corporate plans to take a position over three million dollars in scientific analysis, product improvement and educative packages for well being professionals by 2019.
Lawyer Basic Jeff Periods got here into workplace with the promise of cracking down on hashish – together with medical marijuana – on the federal degree.
In some methods, his mission appears to echo one other famously anti-cannabis politician: Harry J. Anslinger of the 1930s Reefer Insanity period in American historical past, when hashish prohibition was in full swing. However will Periods have the identical impact on American tradition, or has authorized hashish progressed too far?
The Related Press, Huffington Submit, Slate, Chicago Tribune and extra just lately reported that Periods’ threats are filled with smoke.
In line with the AP report, “The Activity Drive on Crime Discount and Public Security, a gaggle of prosecutors and federal regulation enforcement officers, has provide you with no new coverage suggestions to advance the lawyer common’s aggressively anti-marijuana views. The group’s report largely reiterates the present Justice Division coverage on marijuana.”
Is Jeff Periods The Trendy Harry J. Anslinger?
Periods’ feedback on hashish are similar to Harry J. Anslinger’s quotes from almost 100 years in the past, when Anslinger was the the primary commissioner of the U.S. Treasury Division’s Federal Bureau of Narcotics.
Supply: Lawyer Common Jeff Periods, 2017 Supply: Harry J. Anslinger
Anslinger’s anti-cannabis propaganda legacy formed the general public’s understanding of the hashish plant as a nasty behavior of society’s worst degenerates. He used what he referred to as his “Gore Information” – a set of quotes from police studies – to depict alleged offenses brought on by drug customers.
Periods has been portray an identical image of hashish as a “harmful” drug. Earlier this yr, California and Oregon each submitted stories on the outcomes of authorized hashish of their states to Periods’ process drive. Each reported constructive results on public security and native economies.
Supply: Lawyer Basic Jeff Periods, 2016 Supply: Harry J. Anslinger
Periods responded with a July 24 letter, which states that “Congress has decided that marijuana is a harmful drug and that the unlawful distribution and sale of marijuana is a criminal offense, . . . the Division stays dedicated to implementing the Managed Substances Act in a fashion that effectively applies our assets to deal with probably the most vital threats to public well being and security.”
Supply: Lawyer Common Jeff Periods, 2016 Supply: Harry J. Anslinger
Like Brazil and Mexico before it, Paraguay has approved Real Scientific Hemp Oil™ (RSHO™), a non-psychoactive CBD oil, as the first cannabis-based product available in the country. The import permit was granted to the family of Mathias Alejandro Gonzalez, who suffers from a rare form of childhood epilepsy, Lennox-Gastaut syndrome, and autism spectrum disorder. Lennox-Gastaut syndrome is considered an intractable form of epilepsy, meaning it doesn’t respond to traditional treatments. The Gonzalez family was importing expensive but ineffective drugs from Spain when they decided to give RSHO™ a try.
Mathias was diagnosed with both epilepsy and autism.
We couldn’t be more excited that Paraguay is requesting our CBD hemp oil brand, RSHO™, as the first for government-approved importation. It brings full-circle the efforts of creating systems and infrastructure in order to provide reliable access to our CBD hemp oil brands to individuals around the world,” stated Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
The Direccion Nacional de Vigilancia Sanitaria in Paraguay approved the importation certificate on April 15th. The import permit allows the family to acquire one bottle of Medical Marijuana, Inc.’s RSHO™ liquid, which contains 1000 mg of hemp derived CBD. The Gonzalez family had to petition the health authorities in Paraguay for the right to treat their son with CBD hemp oil, arguing that their son deserved to pursue treatment with cannabis as a basic human right.
Paraguay has approved the first import certificate for CBD oil to Mathias.
Unlike in the U.S., where CBD oil products are sold as dietary supplements, many countries classify all forms of cannabis, even hemp, as illegal. However, the hemp derived CBD oil products from Medical Marijuana, Inc. have already been the impetus for change in South and Central America with both Brazil and Mexico approving RSHO™ as a legal import. In the Caribbean, Puerto Rico has authorized the use of medical marijuana for those over 21 with the recommendation of an authorized physician.
The use of Real Scientific Hemp Oil™ has spread recently in Latin America.
In addition to chronic pain, Parkinson’s disease, and epilepsy, Brazil recently added cancer as an indication for the use of RSHO™. Brazil first approved RSHO™ following a grassroots campaign by Medical Marijuana, Inc. and their subsidiary HempMeds® Brasil aimed at educating Brazil’s citizens, doctors, and health officials on the medical benefits of CBD oil.
Mexico also recently permitted the use of CBD oil in their country. The first family approved was that of Grace Elizalde. Grace’s parents, Raul and Mayela Elizalde, are the founders of the Por Grace Foundation, a non-profit organization that has partnered with HempMeds® Mexico to help families interested in accessing a THC-free version of Real Scientific Hemp Oil™ called RSHO-X™. The Por Grace Foundation and the Elizalde family were instrumental in the process of securing the first permit for cannabis in Paraguay for the Gonzalez family.
The Elizalde family became involved in the movement for medical cannabis after their daughter Grace was diagnosed with Lennox-Gastaut syndrome, causing her to suffer from the same autism and seizures as Mathias. Raul began the Por Grace Foundation to raise awareness for RSHO™ for his daughter after he became frustrated with ineffective traditional treatments. Medical Marijuana, Inc. and HempMeds® worked closely with the Elizalde family and Mexican health officials to secure permission for Grace to import RSHO™.
Ever since first allowing the Elizalde family access to RSHO™, the Mexican government has drastically changed direction in their marijuana policy. In a public address in April, Mexican President Peña Nieto laid out his plan to reform cannabis laws. Raul Elizalde preceded the President’s announcement with a sentimental speech commending Mexico’s compassionate new approach to cannabis.
Paraguay has had a tenuous relationship with cannabis since the start of the drug war.
Paraguay is showing signs of following Mexico’s lead. Although possession up to 10 grams is currently decriminalized in Paraguay, the country has otherwise taken a hardline stance on marijuana in the past, adopting a slash and burn policy to eradicate the thousands of hectares of cannabis growing in the rolling hills of Paraguay’s countryside and cracking down on traffickers who move the marijuana throughout Paraguay and over the borders into neighboring countries like Brazil.
Just as Mexico’s President used harsh language regarding cannabis in the past, Paraguay’s President Horacio Cartes has said he is completely against legalizing marijuana, calling it an “addictive drug that destroys lives”. With the approval of RSHO™ for Mathias Gonzalez, Paraguay may be adopting Mexico’s new direction in cannabis policy.
Considering this trend among Latin American countries of adjusting their cannabis laws to fit the changing public acceptance of medical marijuana and rising costs of health care and law enforcement that strain the budgets of these developing economies, Medical Marijuana, Inc. has predicted a pattern of continued growth in the medical cannabis market in Latin America. With Brazil and Mexico already making up a market of over 320 million, Paraguay adds another 7 million citizens who could soon have full access to CBD hemp oil products.
Visit this education page to learn more about CBD and hemp oil or see this convenient guide to CBD hemp oil products.
One company has made it their mission over the past year to expand access to cannabinoid-based products to people across Latin America. Since summer of 2014, Medical Marijuana, Inc. has been the first company to have cannabis products approved for import and use in three separate countries, Brazil, Mexico, and Paraguay, and has shown that is eager to develop additional untapped markets for future development.
Mexico has recently added 22 new patients to its list of those approved to import Real Scientific Hemp Oil™, a form of cannabidiol (CBD) hemp oil sold by Medical Marijuana, Inc. that has shown beneficial effects in those with a number of conditions, including intractable epilepsy, that resist traditional treatments.
Of the 22 patients approved to import Real Scientific Hemp Oil™ or RSHO™, most are adolescents suffering from epilepsy. With little hope in expensive traditional treatments that have proven to be ineffective, the families of these patients have sought out RSHO™ after hearing about the results from other families with epileptic children in Mexico and abroad.
Medical cannabis in Mexico, a country of 120 million residents, represents a significant potential market, estimated to be worth up to $12 billion annually. As the country awaits a second vote on medical marijuana, Medical Marijuana, Inc. is pressing forward with efforts to expand access to their CBD hemp oil products, which provide many of the same benefits as medical cannabis, without the high of marijuana.
“With its more than 120 million residents, Mexico represents a potentially vast market for Medical Marijuana, Inc.,” the company’s CEO Dr. Stuart Titus said. “Our company’s goal is ‘access for all’ and we have already made great strides in Mexico to get our products to the people there suffering with debilitating medical conditions.”
However, medical cannabis wasn’t even a discussion in Latin America before the growth of the CBD hemp oil market.
The conversation started with Medical Marijuana, Inc.’s RSHO™ and a little girl in Brazil. Anny Fischer was born with a severe form of childhood epilepsy. Her mother, Katiele, desperate for a solution, heard about a family in Texas that had experienced previously unheard of success with CBD hemp oil for their daughter’s epilepsy. The mother of that family was Penny Howard, who had been giving her daughter Harper RSHO™ for years.
Anny and Katiele Fischer, the mother and daughter who received the first legal cannabis oil, Real Scientific Hemp Oil, in Brazil.
While the Fischer family fought for right to import RSHO™ to Brazil, Medical Marijuana, Inc. created HempMeds® Brasil to educate local health officials and lawmakers on the benefits of CBD hemp oil and help patients learn how to access RSHO™ for themselves. The Brazilian government has now extended the indications approved for RSHO™ to include epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain and migraines.
When the discussion over RSHO™ next began in Mexico, Medical Marijuana, Inc. was on hand. The company participated in public forums and sponsored educational events. Through its local division, HempMeds® Mexico, they worked with government officials and partnered with local nonprofits like the Por Grace Foundation to spread awareness for CBD hemp oil. What started as a conversation quickly became a movement, and in April of 2016, President Peña Nieto announced that Mexico would take a radical new approach to cannabis regulation.
HempMeds Mexico partner Raul Elizalde is congratulated by Mexican President Enrique Peña Nieto after speech to United Nations.
Even though President Peña Nieto’s cannabis reform legislation in Mexico has been stalled, patients already approved for CBD hemp oil in Mexico can continue to import it. Those interested in applying for an import certificate can learn about the process at the HempMeds® Mexico website.
This model of legalization seen in Brazil and Mexico has already begun to take hold in Latin America, with Paraguay being the most recent country to allow RSHO™ CBD oil to be imported into their country for a child with epilepsy.
Observing the vast medical potential for the use of cannabinoids, the Medical Marijuana, Inc. portfolio of companies is actively developing cannabinoid based pharmaceuticals to further safe access to as many patients as possible.
Kannalife™ Sciences received the first licenses from the U.S. government to develop patent 6,630,507, awarded to the National Institutes of Health. The patent covers the use of cannabinoids as both antioxidants and neuroprotectants, and Kannalife™ Sciences is using it to create novel treatments for hepatic encephalopathy, a brain condition linked to alcohol and pill abuse, and chronic traumatic encephalopathy, which is caused by repeated head injuries and often seen in NFL players.
Another Medical Marijuana, Inc. investment, AXIM® Biotech, created the chewing gum delivery system for cannabinoids, which it has developed into CanChew™ gum, a CBD hemp oil supplement, and MedChew™ RX, a combination THC/CBD gum seeking approval for the treatment of pain and spasticity associated with multiple sclerosis. AXIM® is also beginning proof of concept trials on a cannabinoid-based topical treatment for eczema and psoriasis.
Medical Marijuana, Inc. is also looking to complete clinical trials in Brazil for all approved indications to support the use of RSHO™ as a prescription.
Access to alternative healthcare in Latin America has never been more important. Latin American countries reliably spend less per GDP on healthcare than most comparable countries, and the proliferation of universal healthcare has done little to bring equitable care to patients in Latin American countries. This has created a need for alternative treatments and affordable healthcare options in countries like Mexico, and RSHO™ CBD oil goes a long way to fill that need.
While the value of the potential medical cannabis industry in Brazil hasn’t been calculated, based on comparably sized markets, the country of 200 million could top $20 billion if medical marijuana were legalized. The currently accepted conditions of epilepsy, Alzheimer’s and Parkinson’s diseases, and chronic pain and migraines cover some of the most difficult to treat conditions healthcare encounters. 38% of those with epilepsy in Brazil had inadequate care; 19% were on no treatment at all.
Mexico’s medical cannabis market has been estimated to be worth up to $12 billion. Like in other Latin American countries, healthcare coverage is often deficient. Although CBD hemp oil has only been approved for epilepsy in the country, it constitutes an enormous need. The global epilepsy market is expected to grow to $5.4 billion by 2022.
Dr. Titus concluded, “Despite the pause on a definitive agreement from Mexico legislators, Medical Marijuana, Inc. and our partners in Mexico will continue to fight for Mexican families to expand and ensure legal access to medical marijuana for all those in need of it. In the meantime, RSHO-X continues to be available via a doctor’s prescription as the first legal cannabis-based product within Mexico.”
Although Medical Marijuana, Inc.’s products are now being accepted by select Latin American countries as prescription medications, their CBD hemp oil products have long been available for purchase and shipment across the U.S. and in over 40 countries in Europe, Asia, the Americas as dietary supplements. In these markets, anyone can buy CBD hemp oil supplements without a doctor’s prescription or recommendation and have them shipped directly to their home.
Anyone in the U.S. interested in the health benefits of cannabinoids can get started today by shopping online at medicalmarijuanainc.com/store.